Skip to main content

Day: April 29, 2020

Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology

These previously presented data demonstrated lenabasum improved efficacy outcomes and underlying disease pathology compared to placebo and had an acceptable safety profile in Phase 2 studySystemic sclerosis is a rare autoimmune disease affecting ~200,000 people in the U.S., EU and Japan, and has the highest mortality rate among the systemic autoimmune diseasesPhase 3 study of lenabasum for the treatment of systemic sclerosis is on track for topline results in summer 2020Norwood, MA, April 29, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the publication of results from the double-blind, randomized, placebo-controlled Phase 2 trial assessing...

Continue reading

RigNet Announces First Quarter 2020 Earnings Release Date and Earnings Call Information

HOUSTON, April 29, 2020 (GLOBE NEWSWIRE) — RigNet, Inc. (NASDAQ: RNET) today announced that it will release its first quarter 2020 earnings results before the NASDAQ Exchange opens Friday, May 8th, 2020. This release will be followed by an earnings call for investors on Monday, May 11, 2020, at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) to discuss RigNet’s first quarter 2020 results. The call will be hosted by RigNet President and CEO, Steven Pickett.US and Canadian callers can access the call over the telephone by dialing +1 (877) 845-0777. For international callers, the number is +1 (760) 298-5090. Interested parties can also listen to a simultaneous webcast of the earnings call by logging onto RigNet’s website at www.rig.net in the Investors — Webcasts and Presentation section. A conference-call replay will...

Continue reading

Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models

REDWOOD CITY, Calif., April 29, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit frontier cancer targets, today announced the publication of an original scientific paper in Cancer Research, a journal of the American Association for Cancer Research, describing anti-tumor effects of a SHP2 inhibitor through modulation of key elements of the immune system in preclinical cancer models.  These findings demonstrate that inhibition of SHP2, a cellular protein that plays a central role in cell survival and growth, may exert therapeutic anti-tumor effects by modulating multiple arms of the immune response to the tumor in addition to reducing oncogenic signaling within tumor cells themselves.  Importantly, these data indicate that these...

Continue reading

NXP Announces Launch of Senior Unsecured Notes Offering

EINDHOVEN, The Netherlands, April 29, 2020 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ:NXPI) (together with its subsidiaries, “NXP”) announced today that its subsidiaries NXP B.V., NXP Funding LLC and NXP USA, Inc. (together, the “Issuers”) intend to commence a private offering of senior unsecured notes (the “Notes”) pursuant to Rule 144A and Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”).The Notes will be fully and unconditionally guaranteed on a senior basis by NXP Semiconductors N.V. and will be structurally subordinated to the liabilities, including trade payables, of NXP’s other subsidiaries. In addition, the Notes will be effectively junior to all future secured debt of the Issuers and NXP Semiconductors N.V., to the extent of the value of the assets securing such debt.NXP intends...

Continue reading

VirTra Sets First Quarter 2020 Earnings Call for Tuesday, May 12, 2020 at 4:30 p.m. ET

TEMPE, Ariz., April 29, 2020 (GLOBE NEWSWIRE) — VirTra, Inc. (NASDAQ: VTSI), a global provider of training simulators for the law enforcement, military, educational, and commercial markets, will hold a conference call on Tuesday, May 12, 2020 at 4:30 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2020. Financial results will be issued in a press release prior to the call.VirTra management will host the conference call, followed by a question and answer period.Date: Tuesday, May 12, 2020Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)U.S. dial-in number: 844-369-8770International number: 862-298-0840Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference...

Continue reading

InflaRx Reports Full Year 2019 Financial & Operating Results

End of Phase 2 FDA meeting scheduled to discuss the path forward for IFX-1 in Hidradenitis SuppurativaInitial promising results reported in Pyoderma GangraenosumPart 1 of adaptive randomized trial in severe COVID-19 pneumonia fully enrolledExecuted clinical collaboration agreement in oncology with Merck & Co, Inc., Kenilworth, NJ, USA (known as MSD outside the US and Canada)Senior executives hired for key positionsCash, cash equivalents and financial assets were €115.8 million as of December 31, 2019JENA, Germany, April 29, 2020 (GLOBE NEWSWIRE) — InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today financial results for the year ending December 31, 2019.“The Company underwent significant changes in 2019 and has selected...

Continue reading

Southern Michigan Bancorp, Inc. Announces First Quarter 2020 Earnings

COLDWATER, Mich., April 29, 2020 (GLOBE NEWSWIRE) — Southern Michigan Bancorp, Inc. (OTC Pink: SOMC) announced first quarter net income of $1,513,000, a 21.2% decrease compared to net income of $1,920,000 for the first quarter of 2019. Earnings per share for the first quarter of 2020 were $0.66 per share, a decrease of 20.5% compared to $0.83 per share for the first quarter of 2019.John H. Castle, Chairman and Chief Executive Officer of Southern Michigan Bancorp, Inc., stated, “These are unprecedented times. We are proud of the work our employees are doing to help our customers and each other through this pandemic.”As of March 31, 2020, total consolidated assets were $828.3 million compared to $809.7 million at December 31, 2019.“While our asset quality metrics remained strong at March 31, 2020, the overall impact COVID-19 will...

Continue reading

Ackroo releases 2019 Audited Financial Results reporting 18% YoY growth

HAMILTON, Ontario, April 29, 2020 (GLOBE NEWSWIRE) — Ackroo Inc. (TSX-V: AKR; OTC: AKRFF) (the “Company” or “Ackroo”), a loyalty marketing, gift card and payments technology and services provider, has filed its financial results for the year ended December 31, 2019. The results for the year ended December 31, 2019 reflect 18% year over year revenue growth from 2018 and a 7-year cumulative average growth rate of 36% per year since inception in 2012. The results also include a 25% increase in subscription revenue and a 51% increase in EBITDA over 2018.“2019 was a great year for the Company,” said Steve Levely, CEO at Ackroo. “We once again delivered double digit year over year growth while continuing to improve our technology, services and operations. We acquired and began integrating our largest acquisition to date in IQ724 which...

Continue reading

Republic First Bancorp, Inc. Reports First Quarter Financial Results Loans Grow 27% and Deposits Increase by 19%

PHILADELPHIA, April 29, 2020 (GLOBE NEWSWIRE) — Republic First Bancorp, Inc. (NASDAQ: FRBK), the holding company for Republic Bank, today announced its financial results for the period ended March 31, 2020.Q1-2020 Financial HighlightsTotal loans grew $405 million, or 27%, to $1.9 billion as of March 31, 2020 compared to $1.5 billion at March 31, 2019. Total deposits increased by $466 million, or 19%, to $2.9 billion as of March 31, 2020 compared to $2.5 billion as of March 31, 2019. New stores opened since the beginning of the “Power of Red is Back” expansion campaign are currently growing deposits at an average rate of $24 million per year, while the average deposit growth for all stores over the last twelve months was approximately $16 million per store. Profitability improved compared to the previous quarter as the reported net...

Continue reading

Fidelity D & D Bancorp, Inc. Reports First Quarter 2020 Financial Results

DUNMORE, Pa., April 29, 2020 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary The Fidelity Deposit and Discount Bank, announced net income for the quarter ended March 31, 2020 of $2.6 million, or $0.69 diluted earnings per share, compared to $2.8 million, or $0.73 diluted earnings per share, for the quarter ended March 31, 2019. The $0.2 million, or 6%, reduction in net income resulted primarily from a $0.5 million increase in non-interest expenses. Operating expenses included $0.3 million, or $0.07 per share, of nonrecurring merger-related expenses, net of tax, incurred during the first quarter of 2020. If not for these merger-related expenses, net income would have otherwise increased $0.1 million, or 3%, when compared to the first quarter 2019 period, driven primarily by higher non-interest...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.